Bioterrorism
Advanced Life Sciences Awarded U.S. Department of Defense Biodefense Contract Valued at up to $3.8 Million
Published in Health Risk Factor Week, August 26th, 2008
Advanced Life Sciences Holdings, Inc. (NASDAQ:ADLS), announced that the Defense Threat Reduction Agency (DTRA) of the U.S. Department of Defense has awarded the Company a two-year contract worth up to $3.8 million to further study cethromycin as a potential broad-spectrum medical countermeasure. The contract, part of the agency's Transformational Medical Technologies Initiative (TMTI), will fund NDA-enabling studies evaluating cethromycin's efficacy in combating Category A and B bioterror agents such as Fransicella tularensis (tularemia), Yersinia pestis (plague) and Burkholderia pseudomallei (melioidosis).
"We are very excited to partner with DTRA and share its mission...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
More Articles from Health Risk Factor Week
- Antibiotics
New antibiotics data have been reported by P.L. Hinkson and co-authors - Antivirals
Study results from E. Gong et al provide new insights into antivirals - Bioterrorism
Studies from E.M. Fykse and co-authors have provided new information about bioterrorism - Bird Flu
Inverness Medical Innovations Receives USDA Licensure of the BinaxNOW(R) Avian Influenza Virus Type a Antigen Test Kit - Bird Flu Epidemiology
Researchers from National Chung-Hsing University describe findings in bird flu epidemiology - Burkholderia
Scientists at University of Hawaii target Burkholderia - More from this issue of Health Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
